GROTON, CT, US - Patent application

Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

GROTON, CT US

1. 20110046385 Polymorphs Of Prostaglandin Agonists And Methods For Making The Same 02-24-2011
2. 20110046160 Novel Class of Spiro Piperidines for the Treatment of Neurodegenerative Diseases 02-24-2011
3. 20110039899 Gabapentin for the Treatment of Overactive Bladder, Stress Incontinence and BPH 02-17-2011
4. 20110039884 Imidazopyridinones - to their use in medicine to compositions containing them 02-17-2011
5. 20110039821 Fused Phenyl Amido Heterocyclic Compounds 02-17-2011
6. 20110033447 Methods for Treating Osteoarthritis Pain By Administering a Nerve Growth Factor Antagonist and Compositions Containing the Same 02-10-2011
7. 20110028469 Thiphene-2-Carboxamide Derivatives As Modulators of CCR9 Receptor 02-03-2011
8. 20110028452 PYRIDO[4,3-d]PYRIMIDIN-4(3H)-ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTS 02-03-2011
9. 20110028447 INDAZOLE DERIVATIVES - This invention relates to compounds pharmaceutical compositions and methods for the treatment of a condition mediated by CB1 02-03-2011
10. 20110028390 Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors 02-03-2011
11. 20110020460 GPR 119 MODULATORS - Compounds of Formula I that modulate the activity of the G-protein-coupled receptor GPR119 and their uses in the treatment of 01-27-2011
12. 20110009443 Pyrazolospiroketone Acetyl-Coa Carboxylase Inhibitors 01-13-2011
13. 20110009435 HETERO BICYCLIC CARBOXAMIDE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS 01-13-2011
14. 20110006457 Capsule Formation - method and apparatus for forming hard shell capsule components wherein the capsule components are formed from a material which 01-13-2011
15. 20110005167 Transfer Line - for the transfer of identical filled two-piece capsules between two successive processing stations comprising a and on unloading area 01-13-2011
16. 20110003848 Polymorphic Form Of A [1,2,4]Triazole[4,3-A] Pyridine Derivative For Treating Inflammatory Diseases 01-06-2011
17. 20110002989 METHODS, DOSAGE FORMS AND KITS FOR ADMINISTERING ZIPRASIDONE WITHOUT FOOD 01-06-2011
18. 20100324020 Bicyclic [3.1.0] Heteroaryl Amides As Type 1 Glycine Transport Inhibitors 12-23-2010
19. 20100317712 Estrogen Agonists/Antagonists For Preventing Breast Cancer 12-16-2010
20. 20100317652 Compounds Useful In Therapy - compounds of formula STR00001 or pharmaceutically acceptable derivatives thereof wherein the variables Z 12-16-2010
21. 20100303758 Novel Glucocorticoid Receptor Agonists - This invention relates to novel glucocorticoid receptor agonists of formula : STR00001 and to processes and 12-02-2010
22. 20100300442 Dispensing Device - device for dispensing individual doses of powder from respective pockets of a disc-shaped carrier by outwardly rupturing a lidding 12-02-2010
23. 20100292205 Pyrimidone Compounds As GSK-3 Inhibitors 11-18-2010
24. 20100286214 TRICYCLIC COMPOUNDS, COMPOSITIONS AND METHODS 11-11-2010
25. 20100285145 GPR 119 MODULATORS - Compounds of Formula that modulate the activity of the G-protein-coupled receptor GPR119 and their uses in the treatment of 11-11-2010
26. 20100280016 PYRAZOLINE COMPOUNDS - Compounds and pharmaceutically acceptable salts of the compounds are disclosed wherein the compounds have the structure of 11-04-2010
27. 20100273794 Benzimidazolone Compounds Having 5-HT4 Receptor Agonistic Activity 10-28-2010
28. 20100273758 Sulfonamide Derivatives For The Treatment Of Diseases 10-28-2010
29. 20100267769 Substituted Bicyclocarboxyamide Compounds 10-21-2010
30. 20100267765 Pharmaceutical Compositions and Methods for CCR5 Antagonists 10-21-2010
31. 20100267751 PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING DRY EYE DISORDERS 10-21-2010
32. 20100260775 Treatment Of Interstitial Cystitis - the use of an anti-NGF antibody in the treatment or prevention of pain and/or a lower urinary tract symptom 10-14-2010
33. 20100256213 Tosylate Salt Of Trans-N-Isobutyl-3-Fluoro-3- [3-Fluoro-4-(Pyrrolidin-1-YL-Methyl)-Phenyl] Cyclobut Anecarboxamide 10-07-2010
34. 20100256109 Azetidines As EP2 Antagonists - class of EP2 antagonistazetidines of general formula wherein the variables and substituents are as defined herein 10-07-2010
35. 20100249091 Amide Compounds Useful in Therapy - compound of Formula , or a pharmaceutically acceptable salt or solvate thereof, STR00001 wherein,R 09-30-2010
36. 20100240904 PROCESSES FOR THE PREPARATION OF N-(2-ACETYL-4,6-DIMETHYLPHENYL)-3--2-THIOPHENECARBOXAMIDE 09-23-2010
37. 20100240652 Pyridine Derivatives as Sodium Channel Modulators 09-23-2010
38. 20100234435 CYCLOALKYLAMINO ACID DERIVATIVES - compounds of formula I STR00001 and to pharmaceutically acceptable salts, prodrugs, solvates or hydrates thereof 09-16-2010
39. 20100234285 Benzofuranyl Derivatives - compounds of Formula STR00001 that act as glucokinase activators 09-16-2010
40. 20100227872 PYRAZINE DERIVATIVES - compounds of the formula STR00001 and pharmaceutically acceptable salts and solvates thereof 09-09-2010
41. 20100222365 SUBSTITUTED TRIAZOLE DERIVIATIVES AS OXYTOCIN ANTAGONISTS 09-02-2010
42. 20100216823 Spirocyclic Derivatives - The invention provides compounds of formula : STR00001 wherein m, n, X, R 08-26-2010
43. 20100215654 Methods of treating Osteoarthritis with IL-6 Antagonists 08-26-2010
44. 20100204503 Stereoselective Bioconversion of Aliphatic Dinitriles into Cyano Carboxylic Acids 08-12-2010
45. 20100204455 Antibody Purification Process By Precipitation 08-12-2010
46. 20100204294 Methods For Assessing, Improving, Or Maintaining Urogenital Health in Postmenopausal Woman 08-12-2010
47. 20100204232 XINAFOATE SALT OF N4-(2,2-DIFLUORO-4H-BENZ0 [1,4] OXAZIN-3-ONE) -6-YL] -5-FLUORO-N2- [3-(METHYLAMINOCAR BONYLMETHYLENEOXY) PHENYL] 2,4-PYRIMIDINEDIAMINE 08-12-2010
48. 20100204119 4-AMINO-5-OXO-7,8-DIHYDROPYRIMIDO[5,4-F][1,4]OXAZEPIN-6(5H)-YL PHENYL DERIVATIVES 08-12-2010
49. 20100197591 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES 08-05-2010
50. 20100197590 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES 08-05-2010
51. 20100184777 Substituted Pyrazinone Amides - compounds of Formula STR00001 that act as glucokinase activators 07-22-2010
52. 20100173906 Substituted 3,4,6,7-Tetrahydro-5H-1,2a,4a,8-Tetraazacyclopenta[cd]Phenalenes and Methods 07-08-2010
53. 20100173888 Nicotinamide Derivatives - compounds of the formula STR00001 and pharmaceutically acceptable salts and solvates thereof 07-08-2010
54. 20100168410 Hydroxypropyl Methyl Cellulose Hard Capsules and Process of Manufacture 07-01-2010
55. 20100160648 STEREOSELECTIVE HYDROGENATION PROCESS FOR PREPARING CIS-6-PHENYL-5-[4-(2-PYRROLIDIN-1-YL-ETHOXY)-PHENYL]-2-METHOXY-5,6,7,8-TE- TRAHYDRONAPHTHALENE HYDROCHLORIDE 06-24-2010
56. 20100160314 Small Molecule Inhibitors of Toll-Like Receptor 9 06-24-2010
57. 20100160281 MONOCARBAMS - compounds of formula : STR00001 wherein R 06-24-2010
58. 20100160279 Azetidine Derivatives as Muscarinic Receptor Antagonists 06-24-2010
59. 20100144789 1-Isopropyl-2-Oxo-1,2-dihydropyridine-3-carboxamide Derivatives having 5-HT4 Receptor Agonistic Activity 06-10-2010
60. 20100143400 Immunostimulatory Oligonucleotides - and methods of using immunostimulatory oligonucleotides to induce an antigen-specific immune response 06-10-2010
61. 20100143355 METHODS FOR TREATING PAIN BY ADMINISTERING A NERVE GROWTH FACTOR ANTAGONIST AND AN NSAID AND COMPOSITIONS CONTAINING THE SAME 06-10-2010
62. 20100137316 Morpholine Compounds, Pharmaceutically Acceptable Salts Thereof, Pharmaceutical Compositions, and Methods Of Use Thereof 06-03-2010
63. 20100137283 INHIBITORS OF THE HIV INTEGRASE ENZYME - compounds of formula STR00001 and pharmaceutically acceptable salts and solvates thereof 06-03-2010
64. 20100130784 SUBSTITUTED 1,1,1-TRIFLUORO-3-[(BENZYL)-(PYRIMIDIN-2-YL)-AMINO]-PROPAN-2-OL COMPOUNDS 05-27-2010
65. 20100120858 Piperidine Derivatives - compounds of Formula STR00001 and pharmaceutically acceptable acid addition salts thereof, wherein *, X 05-13-2010
66. 20100120793 Pyrrolidines - This invention relates to a class of pyrrolidine compounds of formula and pharmaceutically acceptable derivatives thereof 05-13-2010
67. 20100119517 Use of Anti-MAdCAM Antibodies for the Treatment of Coeliac Disease and Tropical Sprue 05-13-2010
68. 20100113422 Pyrimido [4,5-D] Azepine Derivatives As 5-HT2C Agonists 05-06-2010
69. 20100113409 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy) azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide 05-06-2010
70. 20100111970 Anti-NGF Antibodies and Methods Using Same 05-06-2010
71. 20100087480 SUBSTITUTED PHENYLMETHYL BICYCLOCARBOXYAMIDE COMPOUNDS 04-08-2010
72. 20100087412 Micronized Eplerenone Compositions - oral pharmaceutical compositions useful as aldosterone receptor blockers comprising the active agent micronized 04-08-2010
73. 20100081718 COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS 04-01-2010
74. 20100069459 NOVEL FORMS OF [R-(R*,R*)]-2-(4-FLUOROPHENYL)-BETA,DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-P- HENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID MAGNESIUM 03-18-2010
75. 20100063064 Substituted Triazole Derivatives As Oxytocin Antagonists 03-11-2010
76. 20100063063 Substituted Heteroaryls - Formula compounds STR00001 that act as glucokinase activators 03-11-2010
77. 20100056618 DIOXA-BICYCLO[3.2.1]OCTANE-2,3,4-TRIOL DERIVATIVES 03-04-2010
78. 20100048498 STABLE NON-DIHYDRATE AZITHROMYCIN ORAL SUSPENSIONS 02-25-2010
79. 20100035891 Pharmaceutically Active Compounds - Compounds of the formula : STR00001 wherein R 02-11-2010
80. 20100035880 SUBSTITUTED SULFONYLAMINOARYLMETHYL CYCLOPROPANECARBOXAMIDE AS VR1 RECEPTOR ANTAGONISTS 02-11-2010
81. 20100035873 Diaryl Compounds and Uses Thereof - derivatives of a compound of formula I: STR00001 wherein R 02-11-2010
82. 20100029753 MODULATORS OF CCR9 RECEPTOR AND METHODS OF USE THEREOF 02-04-2010
83. 20100029720 Carboxamide Derivatives As Muscarinic Receptor Antagonists 02-04-2010
84. 20100029710 COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARy ACTIVATING ACTIVITIES 02-04-2010
85. 20100021966 Method for the Preparation of Growth Hormone and Antagonist Thereof Having Lower Levels of Isoform Impurities Thereof 01-28-2010
86. 20100016366 Novel Compounds Active as Muscarinic Receptor Antagonists 01-21-2010
87. 20100010040 Triazol Derivatives Useful For The Treatment of Diseases 01-14-2010
88. 20100008933 Methods For Treating Obesity By Administering A TRKB Antagonist 01-14-2010
89. 20100004259 Tartrate Salt of (7S)-7-[(5-Fluoro-2-Methyl-Benzyl)oxy]-2-[(2R)-2-Methylpiperazin-1-YL]-6,- 7-Dihydro-5H-Cyclopenta[B]Pyridine 01-07-2010
90. 20100002225 Methods and Apparatus for Maintaining Effective Operation of Apparatus for Candling Avian Eggs 01-07-2010
91. 20090318704 Processes for the Preparation of N-(2-Acetyl-4,6-Dimethylphenyl)-3--2-Thiophenecarboxamide 12-24-2009
92. 20090318497 SUBSTITUTED PYRIDYLMETHYL BICYCLICCARBOXYAMIDE COMPOUNDS 12-24-2009
93. 20090306388 METHOD FOR SUBSTITUTED IH-IMIDAZO[4,5-C] PYRIDINES 12-10-2009
94. 20090306384 Process for the Production of Benzopyran-2-ol Derivatives 12-10-2009
95. 20090306108 SUBSTITUTED PYRIMIDINONES - Disclosed are compounds Formula I STR00001 and pharmaceutically acceptable salts thereof, wherein R 12-10-2009
96. 20090305953 DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS 12-10-2009
97. 20090299093 Preparation of Gamma-Amino Acids Having Affinity for The Alpha-2-Delta Protein 12-03-2009
98. 20090298821 HYDROXY AND ALKOXY SUBSTITUTED IH-IMIDAZONAPHTHYRIDINES AND METHODS 12-03-2009
99. 20090298811 BENZIMIDAZOLONE DERIVATIVES - This invention relates to compounds and methods for the treatment of a condition mediated by CB1 receptor activity in a 12-03-2009
100. 20090298749 DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS 12-03-2009
101. 20090298748 METHODS OF ADMINISTERING DALBAVANCIN FOR TREATMENT OF BACTERIAL INFECTIONS 12-03-2009
102. 20090291977 Chromane Derivatives Useful As Acid Pump Antagonists 11-26-2009
103. 20090291953 PHARMACEUTICAL SALTS OF REBOXETINE - novel crystalline water-soluable salts of the 2S 3S enantiomer of reboxetine 11-26-2009
104. 20090291096 Methods and Apparatus for Selectively Processing Eggs Having Identified Characteristics 11-26-2009
105. 20090281125 Heterocyclic Compounds Useful in Treating Diseases and Conditions 11-12-2009
106. 20090281122 Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase, and Compositions and Treatments Using the Same 11-12-2009
107. 20090275577 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS 11-05-2009
108. 20090275536 Antibacterial Agents - Described herein are antibacterial compounds methods for making the compounds pharmaceutical compositions containing the 11-05-2009
109. 20090270435 Spiroketone Acetyl-CoA Carboxylase Inhibitors 10-29-2009
110. 20090270384 MORPHOLINE DOPAMINE AGONISTS - for compounds of formula , and STR00001 Wherein: A is selected from C--X and N, B is selected from C--Y and N, R 10-29-2009
111. 20090270350 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives 10-29-2009
112. 20090264413 Compositions and Methods for Treating Female Sexual Dysfunction 10-22-2009
113. 20090258861 Tetrahydronaphthyridine Derivatives - of the general formula : STR00001 or of the general formula STR00002 in which A and R 10-15-2009
114. 20090257975 Solid and Semi-Solid Polymeric Ionic Conjugates 10-15-2009
115. 20090253740 SUBSTITUTED N-BICYCLICALKYL BICYCLICCARBOXYAMIDE COMPOUNDS 10-08-2009
116. 20090253739 Amine Derivatives - compounds of formula STR00001 and to processes for the preparation of intermediates used in the preparation of 10-08-2009
117. 20090253674 Substituted Triazole Derivatives As Oxytocin Antagonists 10-08-2009
118. 20090252744 Methods for Treating Bone Cancer Pain by Administering A Nerve Growth Factor Antagonist antibody 10-08-2009
119. 20090247539 Novel Pharmaceuticals - This invention relates to compounds of formula STR00001 10-01-2009
120. 20090247528 METHOD OF TREATING ATTENTION DEFICIT DISORDER 10-01-2009
121. 20090239929 N-Pyrrolidin-3-YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors 09-24-2009
122. 20090239928 N-Pyrrolidin-3YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors 09-24-2009
123. 20090239899 Triazolopyridinylsulfanyl Derivatives As P38 Map Kinase Inhibitors 09-24-2009
124. 20090239883 Treatment of Pulmonary Hypertension - This invention relates to the use of certain cyclic guanosine 3' 5'-monophosphate phosphodiesterase type five 09-24-2009
125. 20090239865 DIBENZYL AMINE COMPOUNDS AND DERIVATIVES 09-24-2009
126. 20090221852 Preparation of an Atorvastatin Intermediate 09-03-2009
127. 20090221839 Preparation of an Atorvastatin Intermediate 09-03-2009
128. 20090221667 Process for Annealing Amorphous Atorvastatin 09-03-2009
129. 20090221556 HYDROXY AND ALKOXY SUBSTITUTED 1H-IMIDAZOQUINOLINES AND METHODS 09-03-2009
130. 20090221551 SUBSTITUTED FUSED[1,2] IMIDAZO[4,5C] RING COMPOUNDS AND METHODS 09-03-2009
131. 20090221546 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE 09-03-2009
132. 20090220489 ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPTIDE AND METHODS USING SAME 09-03-2009
133. 20090215857 Therapeutic Pyrrolidines - for compounds of Formula , STR00001 and pharmaceutically acceptable salts thereof, wherein A, J, Z, and R 08-27-2009
134. 20090214527 Combination Of Anti-Madcam Antibody And Antifibrotic Caspase Inhibitor To Treat Liver Fibrosis 08-27-2009
135. 20090214426 Assay Method - The present invention is related to the field of pharmacy 08-27-2009
136. 20090209577 Novel Triazolopyridine Compounds - This invention is directed generally to triazolopyridine compounds that generally inhibit p38 kinase, TNF, and/or 08-20-2009
137. 20090209548 FORMULATION FOR STIMULATING HAIR GROWTH - topical formulation comprising the Compound 6-[[-3 4-dihydro-3-hydroxy-6-[sulfonyl]-- 2 08-20-2009
138. 20090203782 Alpha 2 Delta Ligands for Fibromyalgia and Other Disorders 08-13-2009
139. 20090203589 CHEMICALLY MODIFIED HUMAN GROWTH HORMONE RECEPTOR ANTAGONIST CONJUGATES 08-13-2009
140. 20090198080 METHOD FOR THE PREPARATION OF ARYL ETHERS 08-06-2009
141. 20090197912 Sulfonamide Derivatives for the Treatment of Diseases 08-06-2009
142. 20090196932 PHARMACEUTICAL COMPOSITIONS OF ATORVASTATIN 08-06-2009
143. 20090196823 Chemokine antagonists as treatment for obesity-related and metabolic syndrome-related conditions 08-06-2009
144. 20090192721 METABOLIC PHENOTYPING - method of generating models with which to characterise selected aspects of the metabolic phenotype of subjects without dosing a 07-30-2009
145. 20090192202 ANDROGEN MODULATORS - new class of 4-cyano-phenoxy-alkyl carboxyl derivatives and to their use as androgen receptor modulators 07-30-2009
146. 20090175793 TREATMENT OF MALE SEXUAL DYSFUNCTION - composition comprising a selective oxytocin antagonist for use in the treatment and/or prevention of a male 07-09-2009
147. 20090171071 PYY Agonists and Uses Thereof - The invention provides PYY 07-02-2009
148. 20090170897 Method of Treating Neuropathic Pain - use of a CRTH2 receptor antagonist in the manufacture of a medicament for the treatment of neuropathic pain and to 07-02-2009
149. 20090170886 ANDROGEN MODULATORS - new class of benzonitriles and to their use as androgen receptor modulators 07-02-2009
150. 20090170852 NOVEL PYRAZOLE-BASED HMG CoA REDUCTASE INHIBITORS 07-02-2009
151. 20090170778 PYY Agonists and Uses Thereof - The invention provides PYY 07-02-2009
152. 20090169595 Controlled Release Polymeric Compositions of Bone Growth Promoting Compounds 07-02-2009
153. 20090162286 Phosphodiesterase 10 Inhibition as Treatment for Obesity-Related and Metabolic Syndrome-Related Conditions 06-25-2009
154. 20090156685 (R)-CHIRAL HALOGENATED SUBSTITUTED FUSED HETEROCYCLIC AMINO COMPOUNDS USEFUL FOR INHIBITING CHOLESTEROL ESTER TRANSFER PROTEIN ACTIVITY 06-18-2009
155. 20090156677 Gabapentin-containing Solid Compositions and Process for Preparing the Same 06-18-2009
156. 20090156618 1-(1- (2-Ethoxyethyl)-3-Ethyl-7-(4-Methylpyridin-2-Ylamino) - 1H-Pyrazolo [4,3-D] Pyrimidin-5-YL) Piperidine-4-Carboxylic acid and salts thereof 06-18-2009
157. 20090149431 Eplerenone Drug Substance Having High Phase Purity 06-11-2009
158. 20090143393 METHOD OF STIMULATING HAIR GROWTH - the discovery that -3 4-dihydro-4-oxy-3-hyd- roxy-6-sulphonyl-2 06-04-2009
159. 20090143387 SUSTAINED-RELEASE TABLET COMPOSITION - sustained-release pharmaceutical composition in a form of an orally deliverable tablet containing reboxetine 06-04-2009
160. 20090143358 INHIBITORS OF ION CHANNELS - Compounds compositions and methods are provided which are useful in the treatment of diseases through the inhibition of 06-04-2009
161. 20090137637 Tetrazolyl-Methylene Amino Acid Derivatives 05-28-2009
162. 20090137584 SULFONYL BENZIMIDAZOLE DERIVATIVES - This invention relates to compounds of the formula : or a pharmaceutically acceptable salt thereof, wherein A, R 05-28-2009
163. 20090137551 Substituted Bicyclolactam Compounds - The invention provides compounds of formula , STR00001 and the pharmaceutically acceptable salt thereof, wherein R 05-28-2009
164. 20090131397 ESTROGEN MODULATORS - The present application is directed to a new class of isoxazoles and their use as estrogen modulators 05-21-2009
165. 20090124820 C1-Symmetric Bisphospine Ligands and Their Use in the Asymmetric Synthesis of Pregabalin 05-14-2009
166. 20090118317 Statin-Carboxyalkylether Combinations - The invention is a pharmaceutical composition comprising a carboxyalkylether which lowers triglycerides and 05-07-2009
167. 20090118316 Methods for Augmenting Bone - methods of stimulating osteoblast function with a PYK2 inhibitor in subjects with osteoporosis 05-07-2009
168. 20090111837 USE OF PDE7 INHIBITORS FOR THE TREATMENT OF NEUROPATHIC PAIN 04-30-2009
169. 20090105349 ANDROGEN MODULATORS - the discovery of a new class of androgen receptor modulators 04-23-2009
170. 20090099364 Process for preparation of 1-(2s,3s)-2-benzhydryl-n-(5- tert-butyl-2-methoxybenzyl)quinuclidin-3-amine 04-16-2009
171. 20090099209 Compounds Useful in Therapy - Compounds of formula , STR00001 or pharmaceutically acceptable derivatives thereof, wherein: R 04-16-2009
172. 20090088465 Pharmaceutical Compositions of Amorphous Atorvastatin and Process for Preparing Same 04-02-2009
173. 20090076152 Novel Compounds Active as Muscarinic Receptor Antagonists 03-19-2009
174. 20090048453 Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-p- yrrole-1-heptanoic acid 02-19-2009
175. 20090042262 Preparation of Pregabalin and Related Compounds 02-12-2009
176. 20090036487 Combinations - The instant invention relates to a combination of an alpha-2-delta ligand and an AChE inhibitor for use in therapy 02-05-2009
177. 20090036459 Melanocortin Type 4 Receptor Agonist Piperidinoylpyrrolidines 02-05-2009
178. 20090036425 SUBSTITUTED BICYCLOLACTAM COMPOUNDS - The invention provides compounds of formula , STR00001 and the pharmaceutically acceptable salt thereof, wherein R 02-05-2009
179. 20090029995 HETERO BIARYL DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS 01-29-2009
180. 20090018158 CRYSTAL FORMS OF AN IMIDAZOLE DERIVATIVE 01-15-2009
181. 20090017508 Streptomyces Avermitilis Gene Directing The Ratio of B2:B1 Avermectins 01-15-2009
182. 20090012079 Triazolopyridine Compounds - compound of formula : or a pharmaceutically acceptable salt and/or solvate thereof or a compound of formula : or a 01-08-2009
183. 20090004655 RNA BIOASSAY - methods for evaluating the cell damaging potential of an agent by determining the ability of the agent to increase messenger RNA release 01-01-2009
184. 20090004268 Methods and Compositions for Treatment of an Interstitial Lung Disease 01-01-2009
185. 20080318982 Pharmaceutical Combination for the Treatment of Luts 12-25-2008
186. 20080318967 Hair Growth Promoting Agents - crystalline forms of 6-[[-3 4-dihydro-3-hydroxy-6-[sulfonyl]-2 2 12-25-2008
187. 20080317851 IMMEDIATE RELEASE DOSAGE FORMS CONTAINING SOLID DRUG DISBURSIONS 12-25-2008
188. 20080312235 Pyridine Derivatives - compounds of the formula and pharmaceutically acceptable salts and solvates thereof 12-18-2008
189. 20080306282 Novel Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-HeptanoicAcid Calcium Salt (2:1) 12-11-2008
190. 20080294071 Assay Method - assay for the assessment of drug side effects particularly the side effect of dizziness comprising the steps of: providing a first 11-27-2008
191. 20080293801 Solid Amorphous Dispersions of An Mtp Inhibitor For Treatment of Obesity 11-27-2008
192. 20080293767 1-Isopropyl-2-Oxo-1,2-Dihydropyridine-3-Carboxamide Derivatives Having 5-Ht4 Receptor Agonistic Activity 11-27-2008
193. 20080293746 COMBINATIONS COMPRISING PREGABALIN - combination of pregabalin and 1--5-[ethylamino]-N-mesyl-7-[a- mino]-1H-pyrazolo[4 11-27-2008
194. 20080293633 Pharmaceutical Formulations, Methods, and Dosing Regimens for the Treatment and Prevention of Acute Coronary Syndromes 11-27-2008
195. 20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug 11-27-2008
196. 20080287521 Crystalline Forms Of [R-(R*,R*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methyl- Ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt (2:1) 11-20-2008
197. 20080287479 INHIBITORS OF SERINE PALMITOYLTRANSFERASE 11-20-2008
198. 20080282364 Phosphodiesterase 9 Inhibition as Treatment for Obesity-Related Conditions 11-13-2008
199. 20080280877 Azetidines - EP2 antagonist azetidines of formula wherein Ar, R 11-13-2008
200. 20080280875 FUSED PHENYL AMIDO HETEROCYCLIC COMPOUNDS 11-13-2008
201. 20080269314 Process for Forming Amorphous Atorvastatin 10-30-2008
202. 20080269310 Synergistic Combinations - This invention relates to synergistic combinations of non-steroidal antiinflammatory drugs particularly carprofen 10-30-2008
203. 20080269293 PYRAZOLE DERIVATIVES AS ANTI-PLATELET AND ANTI-THROMBOTIC AGENTS 10-30-2008
204. 20080269233 Piperidinoyl-Pyrrolidine and Piperidinoyl-Piperidine Compounds 10-30-2008
205. 20080269211 Indazole Derivatives - This invention relates to compounds of the formula : or pharmaceutically acceptable salts thereof, wherein: R 10-30-2008
206. 20080269111 METHOD OF TREATING DYSLIPIDEMIC DISORDER 10-30-2008
207. 20080267970 Sulfonamide Derivatives For The Treatment of Diseases 10-30-2008
208. 20080262074 Salt Forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-5-(1-Methylethyl)-3-(Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid 10-23-2008
209. 20080261995 Pharmaceutical Combination of a Pde-5 Inhibitor and a 5-Alpha Reductase Inhibitor 10-23-2008
210. 20080255113 Quinolonecarboxylic Acid Compounds Having 5-Ht4 Receptor Agonistic Activity 10-16-2008
211. 20080234280 Use of Mc4 Receptor Agonist Compounds - This invention relates to the use of an MC4 receptor agonist compound for the manufacture of a medicament for 09-25-2008
212. 20080234252 Compounds Useful in Therapy - Compounds of formula , or a pharmaceutically acceptable salt, solvate, ester or amide thereof, wherein R 09-25-2008
213. 20080227974 Novel Substituted Azetidinones - Novel azetidinones and pharmaceutical compositions are described as are the methods of using such compounds and 09-18-2008
214. 20080214651 Crystalline forms of [R-(R*, R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) 09-04-2008
215. 20080214622 Substituted Triazole Derivatives As Oxytocin Antagonists 09-04-2008
216. 20080214519 Chromane Substituted Benzimidazole Derivatives as Acid Pump Antagonists 09-04-2008
217. 20080213375 Drying of Drug-Containing Particles - secondary drying process is disclosed for removing residual solvent from drug-containing particles that have been 09-04-2008
218. 20080207755 Alpha 2 Delta Ligands For Fibromyalgia and Other Disorders 08-28-2008
219. 20080207690 Benzisoxazole Derivatives - This invention relates to compounds of the formula : wherein A, B, R 08-28-2008
220. 20080207689 Formamide Derivatives For The Treatment of Diseases 08-28-2008
221. 20080207665 Alpha-(Aryl-or Heteroaryl-Methyl)-Beta-Piperidinopropanoic Acid Compounds as Orl-1-Receptor Antagonists 08-28-2008
222. 20080207651 Heterocyclic compounds useful in treating diseases and conditions 08-28-2008
223. 20080200717 Process For Producing Ethers - The invention is directed to a process for producing the compound 4--2-trifluo-romethyl-benzonitrile or a 08-21-2008
224. 20080200490 Alpha-(Aryl-or Heteroaryl-Methyl)-Beta-Piperidino Propanamide Compounds as Orl-1-Receptor Antagonists 08-21-2008
225. 20080200475 4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors 08-21-2008
226. 20080199527 Enteric Coated Azithromycin Multiparticulates 08-21-2008